(Q53138711)

11 May 2018

title

Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. (English)

1 reference

11 May 2018

Adaptive radiation therapy

main subject

0 references

author

Nicholas G Zaorsky

1

1 reference

11 May 2018

Robert B. Den

object named as

Robert B Den

7

0 references

author name string

Scott W Keith

2

1 reference

11 May 2018

Talha Shaikh

3

1 reference

11 May 2018

Paul L Nguyen

4

1 reference

11 May 2018

Eric M Horwitz

5

1 reference

11 May 2018

Adam P Dicker

6

1 reference

11 May 2018

publication date

1 April 2018

1 reference

11 May 2018

American Journal of Clinical Oncology

published in

1 reference

11 May 2018

volume

41

1 reference

11 May 2018

issue

4

1 reference

11 May 2018

page(s)

409-415

1 reference

11 May 2018

70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.

cites work

1 reference

12 December 2020

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy

1 reference

12 December 2020

Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?

1 reference

12 December 2020

Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.

1 reference

12 December 2020

Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial

1 reference

12 December 2020

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

12 December 2020

Evolution of advanced technologies in prostate cancer radiotherapy

1 reference

12 December 2020

High dose rate brachytherapy boost for prostate cancer: a systematic review

1 reference

12 December 2020

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

1 reference

12 December 2020

What hypofractionated protocols should be tested for prostate cancer?

1 reference

12 December 2020

A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.

1 reference

12 December 2020

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

12 December 2020

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

12 December 2020

Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials

1 reference

12 December 2020

Updated Results and Patterns of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer

1 reference

12 December 2020

Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment

1 reference

12 December 2020

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

12 December 2020

The effect of ethnicity and sexual preference on prostate-cancer-related quality of life

1 reference

12 December 2020

Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study

1 reference

12 December 2020

What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation.

1 reference

12 December 2020

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer

1 reference

12 December 2020

Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer.

1 reference

12 December 2020

The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy

1 reference

12 December 2020

Prostate cancer 2012: where do we stand and where are we heading?

1 reference

12 December 2020

A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.

1 reference

12 December 2020

Cancer treatment and survivorship statistics, 2012

1 reference

12 December 2020

Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer

1 reference

12 December 2020

Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer

1 reference

12 December 2020

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

12 December 2020

Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy

1 reference

12 December 2020

The interpretation of random-effects meta-analysis in decision models.

1 reference

12 December 2020

Is alpha/beta for prostate tumors really low?

1 reference

12 December 2020

10.1097/COC.0000000000000285

Identifiers

DOI

1 reference

11 May 2018

PMC publication ID

7592421

0 references

1 reference

11 May 2018